• References

    Adverse effects of intravenous immunoglobulin therapy. American Academy of Allergy Asthma & Immunology website. Available at: mc/currentliterature/selectedarticles/2003archive/intravenous%5Fimmunoglobulin.html.
    Accessed May 27, 2007.

    Darabi, K, Abdel-Wahab, O, et al. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature.
    2006; 46:741.

    Emerson GG, Herndon CN, et al.
    Pharmacotherapy. 2002;22(12):1638-1641.

    Nydegger UE. Safety and side effects of IV immunoglobulin therapy.
    Clin Exp Rheum. 1996;14(suppl 15):S53-57.

    Orange, JS, Hossny, EM, et al. Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
    J Allergy Clin Immunol.
    2006; 117:S525.

    Sherer Y, Levy Y, et al. Intravenous immunoglobulin therapy of antiphospholipid syndrome.
    Rheumatology. 2000;39:421-426. Available at
    Accessed May 28, 2007.

  • Resources

    National Library of Medicine

  • Canadian Resources

    British Columbia Ministry of Health

    Canadian AIDS Society